Trial · NCT04099901
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Reduction of the incidence of fever during neutropenia | Primary outcome will be determined during the period of hospitalization (day of admission [day -3] until discharge, maximum period +30 days). | |
| Secondary | Reduction in incidence of mucositis-related fever | Outcome will be determined during the period of hospitalization (day of admission [day -3] until discharge, maximum period +30 days). | |
| Secondary | Daily mean CRP level | Outcome will be determined during the period of hospitalization (day of admission [day -3] until discharge, maximum period +30 days). | |
| Secondary | Intestinal mucositis as measured by the area-under-the-curve of reciprocal citrulline levels | Outcome will be determined during the period of hospitalization (day of admission [day -3] until discharge, maximum period +30 days). | |
| Secondary | Clinical mucositis as determined by the daily mouth and gut scores | Outcome will be determined during the period of hospitalization (day of admission [day -3] until discharge, maximum period +30 days). | |
| Secondary | Days with fever (≥ 38.5° C) | Outcome will be determined during the period of hospitalization (day of admission [day -3] until discharge, maximum period +30 days). | |
| Secondary | Incidence of bloodstream infections i.e. bacteremia | Outcome will be determined during the period of hospitalization (day of admission [day -3] until discharge, maximum period +30 days). | |
| Secondary | Length of hospital stay in days | Outcome will be determined during the period of hospitalization (day of admission [day -3] until discharge, maximum period +30 days). | |
| Secondary | Use of systemic antimicrobial agents (incidence and duration) | Outcome will be determined during the period of hospitalization (day of admission [day -3] until discharge, maximum period +30 days). | |
| Secondary | Use of analgesic drugs (incidence and duration) | Outcome will be determined during the period of hospitalization (day of admission [day -3] until discharge, maximum period +30 days). | |
| Secondary | Use of total parenteral nutrition (TPN) (incidence and duration) | Outcome will be determined during the period of hospitalization (day of admission [day -3] until discharge, maximum period +30 days). | |
| Secondary | Quality of life according to the EORTC QLQ-C30 | Baseline, +30 days/discharge (whichever comes first), +100 days, +1 year | Quality of life according to the EORTC QLQ-C30 |
| Secondary | Fatigue severity according to the FACIT-Fatigue scale | Baseline, +30 days/discharge (whichever comes first), +100 days, +1 year | Severity of fatigue as the score measured by the validated FACIT-Fatigue scale |
| Secondary | Short term overall survival | +100 days and +1 year | |
| Secondary | Tumor response evaluation | +100 days and +1 year |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04099901/registered